Before our diagnoses, many of us in the chronic illness world might’ve thought rest simply meant sleep — perhaps a good night in bed or a quiet day on the couch. But living with a chronic, systemic disease teaches us something very different: We can sleep for eight hours and…
Lung damage in people with ANCA-associated vasculitis (AAV) can vary widely depending on the type of self-reactive antibodies driving the disease. That’s according to the findings of a new study of AAV patients in Japan that used images from cast high-resolution CT scans, known as HRCTs. Specifically, the data…
InflaRx plans to launch a Phase 2 clinical trial to evaluate its experimental oral treatment, izicopan, in people with ANCA-associated vasculitis (AAV). The company believes izicopan has the potential to be a safer, faster, and more convenient alternative to Tavneos (avacopan), an oral therapy with a similar…
Becoming educated and informed about ANCA vasculitis is a good first step. Here you’ll find general information such as the diagnosis, symptoms, and causes.
It helps to know others have been where you are now. Here’s a collection of our columnists’ words of wisdom to help you along on your ANCA vasculitis journey.
There is no cure for ANCA vasculitis yet, but here you can find more information about current approved treatments, as well as experimental treatments that are in the pipeline.
Get regular updates to your inbox.
